Company intelligence / Profile preview

Handa Pharmaceuticals, Inc.

Ownership
Private
Development stage
Commercial
01

Overview

Handa Pharmaceuticals, Inc. develops specialty pharmaceuticals with a focus on high-barrier generics, novel formulations using proprietary platforms like ONCORE™, and improved versions of existing drugs. Its lead product PHYRAGO™—an improved dasatinib formulation—has FDA approval for CML/ALL with unique benefits over SPRYCEL®, including safe co-administration with gastric acid-reducing agents. The company has additional generic products approved or partnered in the US market and maintains a pipeline spanning oncology and other therapeutic areas.[1][2][3][5][6]

Therapeutic areas
OncologyOther
Modalities
Small molecules[6][9]Controlled-release formulations[3]Tyrosine kinase inhibitors[4][6]High-barrier generics[1][3]Novel drug delivery technologies[4]
Industry
Biotech
02

Drug pipeline

6 assets

HND032

Preclinical

5 more assets in the full pipeline.

Request access →
03

Partnerships

Cycle Pharmaceuticals (“TASCENSO ODT®” partnership) [8]Par Pharmaceutical (“Dexlansoprazole”, “Quetiapine Fumarate” partnerships) [8]Nanocopoeia, LLC (“PHYRAGO™” asset acquisition) [6]

Beyond the preview

Go deeper on Handa Pharmaceuticals, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Handa Pharmaceuticals, Inc..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call